Research into ENA-001 is also supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R44DA057133. The content of this document is the ...
Funding from the NIH's National Institute on Drug Abuse (NIDA) will Support Development of ENA-001, an Agnostic Respiratory Stimulant, for Community Drug Overdose and as a Medical ...
The study will consist of utilizing both Enalare's new intramuscular (IM) formulation, developed with funding provided by the Biomedical Advanced Research and Development Authority (BARDA), part ...
Jan. 13, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for ...
France is leading a charge against an EU proposal to merge Europe’s health crisis authority with its civil protection unit ...
Velico, Inc. has launched a groundbreaking collaboration with the South Texas Blood and Tissue Center (STBT), a subsidiary of ...
Luminary Labs, a strategy and innovation consultancy, announced today that it has been awarded an OASIS+ Small Business contract. The award highlights Luminary Labs' strong track record of delivering ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...